Malignant neoplasm of cortex of unspecified adrenal gland
ICD-10 C74.00 is a billable code used to indicate a diagnosis of malignant neoplasm of cortex of unspecified adrenal gland.
C74.00 refers to a malignant neoplasm located in the cortex of the adrenal gland, which is responsible for producing hormones such as cortisol, aldosterone, and androgens. These tumors can disrupt normal hormone production, leading to various metabolic and endocrine disorders. Symptoms may include hypertension, weight gain, and abnormal glucose metabolism, depending on the hormones affected. Diagnosis typically involves imaging studies, such as CT or MRI, and may require biopsy for histological confirmation. Treatment options often include surgical resection, radiation therapy, and chemotherapy, depending on the tumor's size, stage, and hormone secretion status. The unspecified nature of the adrenal gland in this code indicates that the specific side (left or right) is not documented, which can complicate treatment planning and prognosis. Accurate coding is essential for appropriate management and reimbursement.
Detailed hormone level assessments and imaging results.
Patients presenting with symptoms of Cushing's syndrome or adrenal insufficiency.
Endocrinologists must document hormone profiles and any metabolic disturbances.
Pathology reports and staging information.
Patients undergoing treatment for adrenal tumors, including chemotherapy and radiation.
Oncologists should document tumor size, grade, and response to treatment.
Used for surgical removal of the adrenal tumor.
Operative report detailing the procedure and findings.
Endocrinologists and oncologists should ensure clear documentation of indications for surgery.
Specifying the side of the adrenal gland is crucial for treatment planning and prognosis, as it can influence surgical approaches and the management of hormone-related symptoms.
